

The Orange Healthcare CD23 (CLL Segregation Marker) Test is a specialised laboratory investigation used to detect the expression of CD23, a cell-surface protein found on certain immune cells, particularly B lymphocytes. CD23 is an important immunophenotypic marker used in the evaluation and classification of B-cell lymphoproliferative disorders, including chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). The Orange Healthcare CD23 (CLL Segregation Marker) Test helps distinguish typical CLL from certain other B-cell malignancies, particularly mantle cell lymphoma, when interpreted as part of a broader flow cytometry panel. CD23 expression is commonly observed in CLL, although expression patterns may vary. A positive CD23 result alone does not confirm CLL, and a negative result does not completely exclude it. Results should be evaluated alongside markers such as CD5, CD19, CD20, CD79b, and CD200, as well as blood counts, clinical findings, and other relevant investigations.

17 Crores+ Samples Processed

World Class Technology Labs

25+ Years of Trust & Experience

Free Home Collection
Price:
Rs. 3,750.00
Rs. 4,875.00
23% OFFSample Type: Blood
Fasting Not Required
Booking Procedure:
- Select your preferred Orange Health test or package on BookMyTest and complete your booking with your details.
- Pick a convenient time slot. A trained eMedic will be assigned and can reach you within 60 minutes of booking or at your scheduled time.
- At your selected time, a trained eMedic will visit your doorstep for safe and hygienic sample collection using a painless single-prick method. Samples are securely stored and transported to certified labs for processing.
- Doctor-verified reports are shared via WhatsApp, email, and the Orange Health app. You can also access them anytime from your registered account.
Frequently Asked Questions (FAQ's):
1. What is the Orange Healthcare CD23 (CLL Segregation Marker) Test?
It is a specialised laboratory test that detects CD23 expression on immune cells to help classify B-cell lymphoproliferative disorders, particularly chronic lymphocytic leukaemia.
2. Why is the CD23 (CLL Segregation Marker) Test performed?
The test is performed to support the diagnosis and classification of CLL and other B-cell disorders and to help distinguish CLL from conditions such as mantle cell lymphoma.
3. What does a positive CD23 result indicate?
Positive CD23 expression on an abnormal B-cell population may support a diagnosis of CLL when other characteristic markers are present. However, CD23 can also be expressed in other B-cell disorders.
4. What does a negative CD23 result indicate?
A negative result indicates that CD23 expression was not detected on the evaluated cell population. It may suggest an alternative immunophenotype, but it does not independently exclude CLL.
5. Is fasting required for the Orange Healthcare CD23 (CLL Segregation Marker) Test?
Fasting is generally not required unless additional investigations require specific preparation.
6. What sample is required for the CD23 (CLL Segregation Marker) Test?
A peripheral blood sample collected in an EDTA tube is commonly used for flow cytometry. Bone marrow aspirate or tissue samples may also be required depending on the clinical indication and testing method.